Wen-jing Wu

Guangdong Provincial Key Laboratory Of Malignant Tumor Epigenetics And Gene Regulation
Guangzhou, 510120, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Correction: Targeting CDH17 Suppresses Tumor Progression in Gastric Cancer by Downregulating Wnt/β-Catenin Signaling.

Correction: Targeting CDH17 Suppresses Tumor Progression in Gastric Cancer by Downregulating Wnt/β-Catenin Signaling.

Journal: PloS one

Published: May 17, 2019

Development and Validation of a Nomogram to Predict the Benefit of Adjuvant Radiotherapy for Patients with Resected Gastric Cancer.

Development and Validation of a Nomogram to Predict the Benefit of Adjuvant Radiotherapy for Patients with Resected Gastric Cancer.

Journal: Journal of Cancer

Published: March 01, 2017

Clinical outcomes of Chinese patients with metastatic colorectal cancer receiving first-line bevacizumab-containing treatment.

Clinical outcomes of Chinese patients with metastatic colorectal cancer receiving first-line bevacizumab-containing treatment.

Journal: Medical oncology (Northwood, London, England)

Published: December 14, 2014

Clinicopathologic and prognostic relevance of ARID1A protein loss in colorectal cancer.

Clinicopathologic and prognostic relevance of ARID1A protein loss in colorectal cancer.

Journal: World journal of gastroenterology

Published: May 21, 2014

Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.

Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.

Journal: Hepatology (Baltimore, Md.)

Published: December 22, 2013

Overexpression of the circadian clock gene Bmal1 increases sensitivity to oxaliplatin in colorectal cancer.

Overexpression of the circadian clock gene Bmal1 increases sensitivity to oxaliplatin in colorectal cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 27, 2013

Primary small cell carcinoma of the esophagus: clinicopathological study of 44 cases.

Primary small cell carcinoma of the esophagus: clinicopathological study of 44 cases.

Journal: BMC cancer

Published: September 04, 2013

S-1-based chemotherapy versus capecitabine-based chemotherapy as first-line treatment for advanced gastric carcinoma: a meta-analysis.

S-1-based chemotherapy versus capecitabine-based chemotherapy as first-line treatment for advanced gastric carcinoma: a meta-analysis.

Journal: PloS one

Published: July 19, 2013

L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer.

L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer.

Journal: Journal of hematology & oncology

Published: March 13, 2013

CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer.

CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer.

Journal: Journal of translational medicine

Published: March 11, 2013

Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer.

Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer.

Journal: Carcinogenesis

Published: January 01, 2013

Targeting CDH17 suppresses tumor progression in gastric cancer by downregulating Wnt/β-catenin signaling.

Targeting CDH17 suppresses tumor progression in gastric cancer by downregulating Wnt/β-catenin signaling.

Journal: PloS one

Published: October 22, 2012

Showing 1-12 of 16

Last Updated: 09/26/2026